Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer
- Conditions
- Prostate Cancer Metastatic
- Interventions
- First Posted Date
- 2018-02-19
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 204
- Registration Number
- NCT03436485
- Locations
- 🇺🇸
University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland, United States
🇺🇸Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸Nebraska Cancer Specialists, Omaha, Nebraska, United States
Pharmacokinetic Study Comparing Tiotropium Easyhaler and Spiriva Handihaler
- First Posted Date
- 2018-01-17
- Last Posted Date
- 2018-06-14
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 24
- Registration Number
- NCT03400241
- Locations
- 🇫🇮
Clinical Pharmacology Unit, Espoo, Finland
Impact of Changing the Dosing Regimen on the PK Profile of ODM-203
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2017-08-07
- Last Posted Date
- 2019-05-14
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 16
- Registration Number
- NCT03240445
- Locations
- 🇬🇧
Quotient Clinical Ltd, Nottingham, United Kingdom
Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI)
- Conditions
- Asthma
- Interventions
- Drug: salmeterol-fluticasone
- First Posted Date
- 2017-08-03
- Last Posted Date
- 2018-04-06
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 64
- Registration Number
- NCT03238482
- Locations
- 🇫🇮
Clinical Pharmacology Unit, Orion Pharma, Espoo, Finland
Pharmacokinetic of Levodopa Study in Healthy Males
- Conditions
- Parkinson Disease
- Interventions
- Drug: Levodopa, carbidopa, ODM-104
- First Posted Date
- 2017-05-04
- Last Posted Date
- 2017-09-26
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 20
- Registration Number
- NCT03140956
- Locations
- 🇫🇮
Clinical Pharmacology Unit, Orion Pharma, Espoo, Finland
Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler
- Conditions
- Asthma
- Interventions
- First Posted Date
- 2017-03-08
- Last Posted Date
- 2017-03-08
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 20
- Registration Number
- NCT03073057
- Locations
- 🇫🇮
Orion Pharma, Clinical Pharmacology Unit, Espoo, Finland
Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus
- Conditions
- Asthma
- Interventions
- Drug: Salmeterol/fluticasone Easyhaler with charcoalDrug: Seretide DiskusDrug: Salmeterol/fluticasone EasyhalerDrug: Seretide Diskus with charcoal
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 64
- Registration Number
- NCT03060044
- Locations
- 🇫🇮
Orion Pharma pharmacology Unit, Espoo, Finland
Dose-finding Pharmacokinetic Study in Healthy Males
- First Posted Date
- 2017-02-16
- Last Posted Date
- 2021-05-27
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 56
- Registration Number
- NCT03055936
- Locations
- 🇩🇪
Nuvisan Pharma Services, Neu-Ulm, Germany
ODM-207 in Patients With Advance Solid Tumours
- First Posted Date
- 2017-01-30
- Last Posted Date
- 2019-10-15
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 36
- Registration Number
- NCT03035591
- Locations
- 🇫🇮
Helsinki University Central Hospital, Department of Oncology, Helsinki, Finland
Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC)
- First Posted Date
- 2016-05-06
- Last Posted Date
- 2018-04-05
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 84
- Registration Number
- NCT02764125
- Locations
- 🇫🇮
Clinical Research Services Turku CRST, Turku, Finland
🇩🇪Study Coordinating Investigator, Harleshausen, Kassel, Germany
🇭🇺Semmelweis Egyetem Neurológiai Klinika, Budapest, Hungary